Target intelligence / Profile preview

Syntaxin-17 (STX17)

Target
STX17
Molecular classification
Qa-SNARE protein, SNARE protein, Tail-anchored membrane protein, Other (autophagy-related protein)
01

Overview

Syntaxin-17 (STX17) is a tail-anchored Qa-SNARE (soluble NSF attachment protein receptor) protein with a pivotal role in mammalian macroautophagy, especially in mediating membrane fusion between autophagosomes and lysosomes to form autolysosomes and thus enable degradation and recycling of cytosolic material[1][3][4]. STX17 contains an N-terminal Habc domain, a Qa-SNARE motif, and two unique tandem transmembrane domains that anchor it to autophagosomal membranes[1][4]. Upon autophagy induction, STX17 is recruited from the cytosol or Golgi to mature autophagosomes, where, in concert with autophagic SNAREs SNAP29 (Qbc-SNARE) and VAMP8 (R-SNARE), it forms a SNARE complex that fuses autophagosomes to lysosomes[1][4]. STX17 also interacts with proteins such as members of the ATG8 family (notably GABARAP), FIP200, and ATG13, and its function is regulated by phosphorylation (notably by TBK1 at serine 202) and by the microtubule-associated protein MAP1B-LC1[2][5]. In addition to its canonical role in membrane fusion during autophagy, STX17 has regulatory roles in autophagy initiation, potential roles in mitochondrial division (through Drp1 recruitment), and lipid droplet dynamics in some species and cell types[3][5]. Defects in STX17-mediated autophagy are implicated in neurodegenerative and age-related diseases, although STX17 itself is not currently a direct drug target and is not established as a clinical biomarker[2][5].

Other names
Syntaxin 17syntaxin-17FLJ20651STX17Syx17SYX-17 (nematodes)
02

Biological functions

Autophagosome–lysosome fusion (essential for macroautophagy and turnover of cellular components)Autophagosome biogenesis/initiation (involvement in protein complexes required for early autophagy steps)Mitochondrial fission/division (especially in some organisms and cellular contexts)Lipid droplet expansion
03

Disease associations

Neurodegenerative disease (linked via defective autophagy)Other (dysfunction in autophagy associated with aging, infection, cancer, but direct associations for STX17 still emerging)
04

Safety considerations

Potential for broad impact on cellular autophagy: Manipulation could impair clearance of protein aggregates and damaged organelles, with deleterious effects in various tissuesImpact on mitochondrial homeostasis: Disruption may alter mitochondrial quality controlUnknown off-target/autophagy-related toxicities: Caution, as broad modulation of SNARE/autophagy machinery can be pleiotropic

Beyond the preview

Go deeper on Syntaxin-17 (STX17).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Syntaxin-17 (STX17).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call